ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,456, issued on March 18, was assigned to Navitor Pharmaceuticals Inc. (Boston).
"Polymorphic compounds and uses thereof" was invented by Silvia Lenzini (Verona, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds and methods useful for selectively modulating mTORC1 activity."
The patent was filed on May 30, 2023, under Application No. 18/203,341.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12252456&OS=12252456&RS=12252456
Disclaimer...